Literature DB >> 28465756

An Invasive Treatment of Pseudomyxoma Peritonei with Intrathoracic Involvement.

Rami Ababneh1, Pompiliu Piso2, Hans-Stefan Hofmann2, Anca Dumitrovici1, Rares Buiga1, Gabriel Samasca3, Claudia Burz1.   

Abstract

Pseudomyxoma peritonei (PP) is a rare disease characterized by the presence of mucinous ascites and low and progressive accumulation of peritoneal implants. We report the case of a 44-year-old man presented with ascites, imaging evaluations suggesting the diagnosis of gelatinous peritoneal carcinomatosis. The patient underwent laparoscopy with extensive cytoreductive surgery combined with hyperthermic intraoperative peritoneal chemotherapy (HIPEC). Microscopic features confirmed the diagnosis of low-grade PP. Nine months later the patients developed left pleural effusion and cytological examination releaved the intrathoracic extension of PP. The treatment consisted in extensive intrathoracic cytoreductive surgery in combination with hyperthermic intrathoracic chemotherapy perfusion (HITOC). Further surgery was requiered due to intra-abdominal recurrence and finally, the patient developed hepatic and pulmonary metastases treated by systemic chemotherapy, with good tolerability and complete response.

Entities:  

Year:  2016        PMID: 28465756      PMCID: PMC5394494     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  5 in total

Review 1.  Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach.

Authors:  Paul H Sugarbaker
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

Review 2.  Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review.

Authors:  Kim R Geisinger; Edward A Levine; Perry Shen; Robert F Bradley
Journal:  Am J Clin Pathol       Date:  2007-01       Impact factor: 2.493

3.  Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.

Authors:  Rasmy Loungnarath; Sylvain Causeret; Nadine Bossard; Mohamed Faheez; Annie-Claude Sayag-Beaujard; Cécile Brigand; François Gilly; Olivier Glehen
Journal:  Dis Colon Rectum       Date:  2005-07       Impact factor: 4.585

4.  Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.

Authors:  S R Pestieau; J Esquivel; P H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2000-04       Impact factor: 5.344

5.  Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience.

Authors:  Jamie F Shapiro; Judy L Chase; Robert A Wolff; Laura A Lambert; Paul F Mansfield; Michael J Overman; Aki Ohinata; Jun Liu; Xuemei Wang; Cathy Eng
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

  5 in total
  1 in total

Review 1.  Pseudomyxoma Peritonei: Case Report and Literature Review.

Authors:  Keishla M García; Karla M Flores; Alejandro Ruiz; Frances L González; Ángel M Rodríguez
Journal:  J Gastrointest Cancer       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.